The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp with lenalidomide and rituximab for…
New Houston Methodist research has revealed that a protein associated with neurodegenerative diseases such as dementia and amyotrophic lateral sclerosis (ALS) also plays a…
Findings from a preclinical study led by VHIO’s Models of Cancer Therapies Group, directed by…
The nuclear pore complex (NPC) is an active and highly selective barrier that controls what…
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
On November 19, 2025, the Food and Drug Administration approved selumetinib for adults with neurofibromatosis…
On November 18, 2025, the Food and Drug Administration approved epcoritamab-bysp with lenalidomide and rituximab for…
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast…
University of South Australia scientists have developed a powerful new way to uncover the genetic…